Ruzzi, Francesca; Riccardo, Federica; Conti, Laura; Tarone, Lidia; Semprini, Maria Sofia; Bolli, Elisabetta; Barutello, Giuseppina; Quaglino, Elena; Lollini, Pier-Luigi; Cavallo, Federica, Cancer vaccines: Target antigens, vaccine platforms and preclinical models, «MOLECULAR ASPECTS OF MEDICINE», 2025, 101, Article number: 101324, pp. 1 - 17 [articolo]Open Access
Angelicola, Stefania; Giunchi, Francesca; Ruzzi, Francesca; Frascino, Mariateresa; Pitzalis, Mary; Scalambra, Laura; Semprini, Maria Sofia; Pittino, Olga Maria; Cappello, Chiara; Siracusa, Irene; Chillico, Ilaria Candida; Di Noia, Martina; Turato, Cristian; De Siervi, Silvia; Lescai, Francesco; Ciavattini, Teresa; Lopatriello, Giulia; Bertoli, Luca; De Jonge, Hugo; Iamele, Luisa; Altimari, Annalisa; Gruppioni, Elisa; Ardizzoni, Andrea; Rossato, Marzia; Gelsomino, Francesco; Lollini, Pier-Luigi; Palladini, Arianna, PD-L1 and IFN-γ modulate Non-Small Cell Lung Cancer (NSCLC) cell plasticity associated to immune checkpoint inhibitor (ICI)-mediated hyperprogressive disease (HPD), «JOURNAL OF TRANSLATIONAL MEDICINE», 2025, 23, Article number: 2, pp. 1 - 20 [articolo]Open Access
Scalambra, Laura; Ruzzi, Francesca; Pittino, Olga Maria; Semprini, Maria Sofia; Cappello, Chiara; Angelicola, Stefania; Palladini, Arianna; Nanni, Patrizia; Goksøyr, Louise; Fougeroux, Cyrielle; Penichet, Manuel L; Sander, Adam Frederik; Lollini, Pier-Luigi, Targeting PCSK9, through an innovative cVLP-based vaccine, enhanced the therapeutic activity of a cVLP-HER2 vaccine in a preclinical model of HER2-positive mammary carcinoma, «JOURNAL OF TRANSLATIONAL MEDICINE», 2025, 23, Article number: 136, pp. 1 - 15 [articolo]Open Access
Di Federico, Alessandro; Angelicola, Stefania; Frascino, Mariateresa; Siracusa, Irene; Bisanti, Beatrice; Ruzzi, Francesca; Semprini, Maria Sofia; De Jonge, Hugo; De Giglio, Andrea; Sperandi, Francesca; Brocchi, Stefano; Melotti, Barbara; Giunchi, Francesca; Gruppioni, Elisa; Altimari, Annalisa; Lollini, Pier-Luigi; Ardizzoni, Andrea; Palladini, Arianna; Gelsomino, Francesco, Clinical and Preclinical Activity of EGFR Tyrosine Kinase Inhibitors in Non-Small-Cell Lung Cancer Harboring BRAF Class 3 Mutations, «JCO PRECISION ONCOLOGY», 2024, 8, Article number: e2400240, pp. 1 - 9 [articolo]Open Access
Ruzzi F.; Semprini M.S.; Scalambra L.; Angelicola S.; Cappello C.; Pittino O.M.; Nanni P.; Palladini A.; Lollini P.L., Functional evaluation of circulating anti-cancer antibodies with a 3D tumor cell growth inhibition assay, «METHODS IN CELL BIOLOGY», 2024, 190, pp. 75 - 86 [articolo]
Ruzzi, Francesca; Cappello, Chiara; Semprini, Maria Sofia; Scalambra, Laura; Angelicola, Stefania; Pittino, Olga Maria; Landuzzi, Lorena; Palladini, Arianna; Nanni, Patrizia; Lollini, Pier-Luigi, Lipid rafts, caveolae, and epidermal growth factor receptor family: friends or foes?, «CELL COMMUNICATION AND SIGNALING», 2024, 22, Article number: 248, pp. 1 - 10 [articolo]Open Access
Ruzzi, F; Palladini, A; Clemmensen, S; Strobaek, A; Buijs, N; Domeyer, T; Dorosz, J; Soroka, V; Grzadziela, D; Rasmussen, CJ; Nielsen, IB; Soegaard, M; Semprini, MS; Scalambra, L; Angelicola, S; Landuzzi, L; Lollini, PL; Thorn, M, Preclinical activity of ES2B-C001, a human candidate HER-2 virus-like particle (VLP) vaccine, against mammary carcinoma onset and metastasis, «CANCER RESEARCH», 2023, 83, pp. 687 - 687 [abstract]
Ruzzi F.; Semprini M.S.; Scalambra L.; Palladini A.; Angelicola S.; Cappello C.; Pittino O.M.; Nanni P.; Lollini P.-L., Virus-like Particle (VLP) Vaccines for Cancer Immunotherapy, «INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES», 2023, 24, Article number: 12963, pp. 1 - 21 [articolo]Open Access
Ruzzi, Francesca; Angelicola, Stefania; Landuzzi, Lorena; Nironi, Elena; Semprini, Maria Sofia; Scalambra, Laura; Altimari, Annalisa; Gruppioni, Elisa; Fiorentino, Michelangelo; Giunchi, Francesca; Ferracin, Manuela; Astolfi, Annalisa; Indio, Valentina; Ardizzoni, Andrea; Gelsomino, Francesco; Nanni, Patrizia; Lollini, Pier-Luigi; Palladini, Arianna, ADK-VR2, a cell line derived from a treatment-naïve patient with SDC4-ROS1 fusion-positive primarily crizotinib-resistant NSCLC: a novel preclinical model for new drug development of ROS1- rearranged NSCLC, «TRANSLATIONAL LUNG CANCER RESEARCH», 2022, 11, pp. 2216 - 2229 [articolo]Open Access
Ruzzi, Francesca; Palladini, Arianna; Clemmensen, Stine; Strøbæk, Anette; Buijs, Nicolaas; Domeyer, Tanja; Dorosz, Jerzy; Soroka, Vladislav; Grzadziela, Dagmara; Rasmussen, Christina Jo; Nielsen, Ida Busch; Soegaard, Max; Semprini, Maria Sofia; Scalambra, Laura; Angelicola, Stefania; Landuzzi, Lorena; Lollini, Pier-Luigi; Thorn, Mette, Prevention and Therapy of Metastatic HER-2+ Mammary Carcinoma with a Human Candidate HER-2 Virus-like Particle Vaccine, «BIOMEDICINES», 2022, 10, Article number: 2654, pp. 1 - 17 [articolo]Open Access
